Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
dapagliflozin (farxiga) (1 trial)
dexamethasone (1 trial)
etoposide (vepesid) (1 trial)
insulin aspart (novolog) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
metformin (glucophage) (1 trial)
olanzapine (zyprexa) (1 trial)
ribavirin (virazole) (1 trial)
ruxolitinib (jakafi) (1 trial)
saxagliptin (onglyza) (1 trial)
atorvastatin (lipitor) (1 trial)
bone marrow derived mesenchymal stem cells (1 trial)
ceftazidime (fortaz) (1 trial)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Herpangina (Phase 4)
Infarction (Phase 2)
Lung Neoplasms (Phase 4)
Myocardial Infarction (Phase 2)
Nausea (Phase 4)
Vomiting (Phase 4)
Trials (6 total)
Trial APIs (13 total)